Bianchi C, Baiardi P: Cough peak flows: standard values for children and adolescents. Am J Phys Med Rehabil 2008;87:461-467. Objective: We describe the distribution of cough peak flows (CPFs) in a random population of healthy children and adolescents.
Peak expiratory flow measurements are used to estimate airway patency and bronchospasm for asthmatics, and standard values are available for both children and adults. 1 More recently, cough peak flow (CPF) measurements have been correlated with success of extubation and as criteria for tracheostomy tube decanulation, 2 and with the risk of acute respiratory failure from ineffective coughing in adults with neuromuscular disorders. 3 Although threshold levels of CPF are used clinically, and normal values range from 400 to 1200 liters/ min for adults, 4 CPFs have not been standardized for children. With increasing attention being given to the effect of neuromuscular weakness on CPF [5] [6] [7] and on the efficacy of strategies to enhance CPF to decrease the risk of respiratory complications, we studied 649 normal children to establish standardized values.
MATERIALS AND METHODS

Subjects and Variables
This study was carried out on all children from six schools, including three nursery schools, two middle schools, and one high school, who met the inclusion criteria and did not meet the exclusion criteria. Inclusion and exclusion criteria included adequate cooperation for testing, nonsmoking, no history or clinical evidence of disease affecting pulmonary function, no recent pulmonary infections, no spine or chest deformities, and normal pulmonary function as defined by forced vital capacity (FVC), peak expiratory flow rate (PEFR), and forced expiratory volume in 1 sec (FEV 1 ) greater than 80% of predicted normal, 8 using Knudson normal values. 9 Failure to obtain written informed consent also excluded the subject. Gender, weight, standing height, body mass index (BMI), and body mass surface (BMS) were also recorded.
Measurements
Each subject, without previous experience in performing spirometry, was shown the apparatus used for testing lung function and for producing the cough. A particular explanation was used for the younger children. All subjects attended for one session lasting at least 15 mins, following their compliance at the different tests.
Each subject was instructed by a single, nonblinded technician, to reduce interobserver variability. The testing was done in sitting position in a chair with no armrest, using the American Thoracic Society standard. 10 A portable spirometer (Spirolab Spirometer-MIR SRL, Italy) meeting American Thoracic Society recommendations for accuracy and precision was used. The subjects were asked to blow as forcibly as they could into a mouthpiece from a full inspiration. In younger children, we took care to eliminate possible artifacts from coughing from the maximal inspiration or failure to achieve maximum effort. Although the use of nose clips has been reported not to introduce bias into the spirometric measurements, 11 we decided, nevertheless, not to use them for all the subjects, to avoid fear in the younger children.
A minimum of three trials was performed. The highest values of FVC, PEFR, FEV 1 , and CPF were recorded. An Assess Peak Flow Meter (Health Scan Products Inc.; Cedar Grove, NJ) was used for flow measurements. With the indicator at the bottom of the meter scale of the device, the subjects were instructed to take a full inspiration and then cough as forcibly as they could into a face mask connected to the meter. They were asked to produce a single cough rather than a sequential one. First, they coughed in sitting position, then supine, then again in sitting position. In several subjects, the second test in the sitting position resulted in higher CPF. The highest observed value was recorded, and this was always in the sitting position.
12,13 When a child reached the top of the scale on the "low-range" peak flow meter, the "standard" adult model was employed.
Statistical Analysis
Distribution of the evaluated variables was inspected by frequency histogram of the total population. The Kolmogorov-Smirnov test (K-S) was used to test distributions for normality. Logarithmic transformations were applied to normalize skewed distributions. Linear multiple regression analysis was used with normally distributed variables (raw values or log-transformed) to test correlations with gender, age, and anthropometric measurements as independent variables and with CPF level as the dependent variable. Reference values for CPF were presented as regression lines and 95% CI in a graphic format. Percentiles of CPF according to age were also estimated on the logtransformed values, and the antilogarithms of the estimates are presented. Data are reported separately for males and females.
Linear correlation analysis between CPF and spirometric variables was carried out, and significance was based on the r 2 value and analysis of residuals.
RESULTS
Population Characteristics and Distribution of Data
There were 649 study subjects who were able to carry out the testing; they included 341 females (52.5%) and 308 males (47.5%), distributed in the range from 4 to 18 yrs as reported in Figure 1 . All but three subjects were Caucasian people.
The total number of screened subjects was 707. Thus, 8% of potential subjects were excluded on the basis of inadequately exhaling to FVC, PEFR, and FEV 1 lower than 80% and not exceeding normal.
Subjects were all within the normal range for height and weight, being the 5th, 50th, and 95th percentiles of BMI equal to 13.4, 18.1, and 24.8 kg/m 2 in males. Similar levels were found in females (13.7, 18.3, and 25.1 kg/m 2 ). BMS 5th, 50th, and 95th percentiles were 0.74, 1.21, and 1.99 m 2 in males and 0.73, 1.31, and 1.74 m 2 in females. Anthropometric data-except BMI, which was proved to be normally distributed after a logarithmic transformation-were assumed to be normally distributed on graphical inspection, even if the K-S test showed a discrepancy from normality. Neither logarithmic nor other transformations were entirely satisfactory in improving the normality of data distribution. As a consequence, these variables have been analyzed as raw values, taking into account the robustness of the parametric tests in hypothesis violation. On the other hand, the respiratory variables-except PEFR, which was normally distributed-were normally distributed after a logarithmic transformation.
Distribution characteristics of the analyzed variables are shown in Table 1 . Gender, age (r ϭ 0.89, P Ͻ 0.001), height (r ϭ 0.92, P Ͻ 0.001), and weight (r ϭ 0.86, P Ͻ 0.001) were strongly correlated with CPF, as shown by multiple regression analysis. Applying a stepwise procedure, the whole set of variables was maintained in the model. Including BMI and BMS in place of height and weight, the model with BMS improved the correlation opposite that including BMI, which resulted in lower r 2 values. 
Spirometric Variables and CPF Reference Levels
FIGURE 1 Age and gender distribution of the analyzed subjects.
Taking into account the correlations among the above-mentioned variables, particularly the age relationship with height (r ϭ 0.96 and 0.92 in males and females, respectively), height and BMS were identified as the major predictors of CPF, also considering that these variables could affect the size of normal lung and, hence, CPF levels.
CPF levels in the pediatric population were, thus, predicted according to the regression lines between CPF and height and BMS. A graphical representation of the relationships is reported in Figure 2a -c, together with the regression equations. Considering the strong correlation between gender and CPF, the analyses were performed separated by gender. Table 2 provides empirical percentiles of CPF distributions in both males and females according to age. Even if height and BMS resulted in better CPF predictive factors than age, percentiles were reported according to age to make it easier for physicians to access reference values in their clinical practice.
Finally, CPFs correlate with all other respiratory variables. Correlation coefficients higher than 0.93 have been found for FVC (r ϭ 0.93), FEV 1 (r ϭ 0.94), and PEFR (r ϭ 0.93).
DISCUSSION
A frequent complication of respiratory diseases is airway congestion by tracheobronchial secretions. This can occur when patients are unable to generate sufficient flows to cough out the debris. It has been stated that some of the techniques to assess respiratory muscle function in children lack validation and standard values.
14 These must include CPF.
FIGURE 2 Scatterplots, regression lines, and 95% CI of ln(CPF) vs. height and BMS for males (a, c) and females (b, d).
Although it has been reported that CPF values below 160 liters/min correlate with extubation and decanulation failure for adults, 2 no flows have been suggested for children. The first publication that considered CPF in normal subjects was published by Leiner et al. 15 in 1966. Two more recent papers have included data on small numbers of children below the age of 18 yrs (7-16 yrs). 16, 17 In fact, the two papers enrolled 7 and 25 subjects, respectively, but they do not provide absolute values of CPF. On the contrary, they demonstrate an increasing rate of change of cough flow during a cough sequence when children get older. Moreover, PEFR cannot be considered as a surrogate measure of cough efficiency. 4, 18 PEFR measures expiratory flow through an open glottis, whereas the forceful expiratory flow of a normal cough follows a glottic closure of about 0.2 secs. As a consequence, CPF measurements directly assess bulbar-innervated muscle function. 6 PEFR can be measurable in the absence of CPF, when the glottis cannot be closed and the risk of laryngeal penetration and pulmonary morbidity is high.
The fact that our data show a linear relationship between CPF and age and height can be considered consistent with data published by other authors pointing out correlations between pulmonary function measurements (FVC, vital capacity) and anthropometric variables. 19, 20 In our study, CPFs were generally higher in males than in females, even though the trends with age and height were similar. Similarly, no modifying effect of gender on the relationship between spirometric variables and height, age, and BMI was reported by Pistelli et al. 21 Notably, the minimum CPF accepted as normal for the adult population (400 liters/min) is shown to be reached in the pediatric subjects between ages 12 and 13 in both males and females.
According to Suárez and coworkers, 22 CPFs were higher than PEFRs, in contrast with the results of a previous study, 15 which has reported CPF Females   5th  10th  25th  50th  75th  90th  95th   4  110  112  124  147  179  202  209  5  125  132  171  185  219  245  273  6  161  161  191  230  242  284  317  7  179  200  228  247  265  302  330  8  200  219  270  299  321  340  351  9  270  270  290  311  347  369  369  10  270  284  299  330  361  380  399  11  296  299  347  380  399  441  478  12  305  340  361  399  412  450  459  13  311  330  361  395  441  508 7  200  211  235  270  299  340  351  8  215  247  279  299  321  340  347  9  217  237  293  311  340  372  424  10  250  260  296  321  351  380  428  11  290  299  340  369  399  420  441  12  311  317  334  369  399  450  498  13  321  337  392  450  518  567  578  14  380  395  498  608  672  713  750  15  380  428  534  633  706  788  829  16  493  518  539  652  713  728  871  17  498  545  561  645  846  898  944  18  518  545  602  728  880  898  944 values as slightly lower than PEFR values in normal subjects. Our results are consistent with the findings of Suárez et al., 22 as seen in the regression equation relating the two variables. Moreover, our PEFR range (60 -720 liters/min) does not substantially differ from the 120-to 840-liter-per-minute range for children and adolescents as reported by other authors, with higher values in adolescents close to adults. Our lower inferior limit seems justified by the inclusion in the research of very young children. 1, 23 As with previous studies, 24 our research points out the feasibility of performing spirometric and pulmonary measurements in very young school children. We excluded 8% of the sample, but this is in line with other published studies. 20, 21 Moreover, a study on perceived ease of performance for spirometry and CPF determination in boys with Duchenne muscular dystrophy with a mean age of 12.6 yrs (range 6 -18 yrs) has reported that these subjects had difficulty coughing into a mask as opposed to performing spirometry via a mouthpiece. 25 Despite this difficulty, CPF values were closely associated with spirometric values, a finding confirmed in our research on normal subjects. The correlation of CPF with age is consistent with the fact that children generate lower expiratory pressures and lower maximal flows than do adolescents and adults. 26 CPF testing, as well as spirometry, should be considered a mainstay in the clinical assessment of patients with neuromuscular weakness. CPF determination is easy, objective, and reproducible. 22 Unassisted CPF can be increased by manual cough assistance as already described, and it has been demonstrated to prevent hospitalizations and pulmonary morbidity. 27 Although the interesting paper of Dohna-Schwake et al. 28 represents a first step in showing how FVC and CPF are strong predictors of severe chest infections in pediatric neuromuscular disorders, the threshold value of CPF unfortunately is not related to a specific group of patients below the age of 10 yrs. Our study provides initial information for determining how far below normal values it needs to go to have high risk of pneumonia as a function of age, height, and other factors; how extensively CPF values decrease during illness; and how this affects pneumonia risk.
Therefore, further clinical studies need to be designed to determine which threshold levels of CPF result in increased morbidity for pediatric patients with respiratory muscle weakness.
